UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy

Frontiers in immunology, 2021-03, Vol.12, p.593288-593288

2021

Link zum Volltext

Verfügbarkeit prüfen

Complement Inhibition in ANCA-Associated Vasculitis

Frontiers in immunology, 2022-07, Vol.13, p.888816-888816

2022

Link zum Volltext

Verfügbarkeit prüfen

AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats

Scientific reports, 2021-02, Vol.11 (1), p.4271-4271, Article 4271

2021

Link zum Volltext

Verfügbarkeit prüfen

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives

Frontiers in immunology, 2022-11, Vol.13, p.1024068-1024068

2022

Link zum Volltext

Verfügbarkeit prüfen

Belimumab in the management of systemic lupus erythematosus - an update

Expert opinion on biological therapy, 2017-07, Vol.17 (7), p.901-908

2017

Link zum Volltext

Verfügbarkeit prüfen

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives

Kidney & blood pressure research, 2020-03, Vol.45 (2), p.157-165

2020

Link zum Volltext

Verfügbarkeit prüfen

Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis

Clinical journal of the American Society of Nephrology, 2020-08, Vol.15 (8), p.1103-1111

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis

International journal of molecular sciences, 2022-04, Vol.23 (8), p.4344

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2064

2023

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis

Frontiers in immunology, 2023-03, Vol.14, p.1122972-1122972

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of high‐flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation

ESC Heart Failure, 2021-06, Vol.8 (3), p.2165-2171

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of proliferative lupus nephritis: a slowly changing landscape

Nature reviews. Nephrology, 2011-02, Vol.7 (2), p.96

2011

Link zum Volltext

Verfügbarkeit prüfen

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy

Biomolecules (Basel, Switzerland), 2023-07, Vol.13 (7), p.1093

2023

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association–European Dialysis and Transplant Association Registry

American journal of kidney diseases, 2015-10, Vol.66 (4), p.613-620

2015

Link zum Volltext

Verfügbarkeit prüfen

Avacopan in the treatment of ANCA-associated vasculitis

Expert opinion on investigational drugs, 2018-05, Vol.27 (5), p.491-496

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?

Clinical journal of the American Society of Nephrology, 2020-10, Vol.15 (10), p.1519-1521

2020

Link zum Volltext

Verfügbarkeit prüfen

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

Frontiers in cardiovascular medicine, 2023-06, Vol.10, p.1130618-1130618

2023

Link zum Volltext

Verfügbarkeit prüfen

Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients

Journal of nephrology, 2022-05, Vol.35 (4), p.1065-1068

2022

Link zum Volltext

Verfügbarkeit prüfen

Rituximab for treatment of severe renal disease in ANCA associated vasculitis

Journal of nephrology, 2016-04, Vol.29 (2), p.195-201

2016

Link zum Volltext

Verfügbarkeit prüfen

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Kidney international, 2017-09, Vol.92 (3), p.693-702

2017

Link zum Volltext

Verfügbarkeit prüfen

Echocardiography in patients with chronic kidney diseases

Cor et vasa (English ed.), 2018-06, Vol.60 (3), p.e287-e295

2018

Link zum Volltext

Verfügbarkeit prüfen

Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience

European journal of hospital pharmacy. Science and practice, 2019-07, Vol.26 (4), p.210-213

2019

Link zum Volltext

Verfügbarkeit prüfen

Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus

Expert opinion on biological therapy, 2018-09, Vol.18 (9), p.989-996

2018

Link zum Volltext

Verfügbarkeit prüfen

ANCA Vasculitis Induction Management During the COVID-19 Pandemic

Kidney international reports, 2021-11, Vol.6 (11), p.2903-2907

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(107)

Sprache

Englisch
(107)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy

Complement Inhibition in ANCA-Associated Vasculitis

AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives

Belimumab in the management of systemic lupus erythematosus - an update

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives

Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis

Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis

The effect of high‐flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation

Treatment of proliferative lupus nephritis: a slowly changing landscape

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association–European Dialysis and Transplant Association Registry

Avacopan in the treatment of ANCA-associated vasculitis

Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients

Rituximab for treatment of severe renal disease in ANCA associated vasculitis

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Echocardiography in patients with chronic kidney diseases

Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience

Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus

ANCA Vasculitis Induction Management During the COVID-19 Pandemic

Suchergebnisse filtern